Postmenopausal survivors of breast cancer at risk for osteoporosis: Nutritional intake and body size

Ada M. Lindsey, Gloria Gross, Janice J Twiss, Nancy Lauraine Waltman, Carol Ott, Timothy Eisdell Moore

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Postmenopausal survivors of breast cancer for whom hormone replacement therapy is contraindicated are at risk for development of osteoporosis. The primary purpose of this article is to describe, in a sample of 30 postmenopausal survivors of breast cancer, their calcium and vitamin D intake compared with recommended dietary guidelines for those nutrients for postmenopausal women not taking hormone replacement therapy and the body mass index of these women as nutritional status risk factors for development of osteoporosis. Bone health and presence of osteoporosis were determined by bone mineral density testing of the spine, hip, and forearm. To obtain calcium and vitamin D intake, including supplements, 3-day diet records were completed; height and weight measures were used to calculate body mass index. The sample participants ranged in age from 42 to 65 years; the majority (56%) had been menopausal or off hormone replacement therapy for 5 years or less, and 70% had completed breast cancer treatment for 5 years or less (except tamoxifen). The majority (63%) were of medium body frame size; 30% were of small frame size. The mean body mass index (27.3) and mean weight (160 lbs) indicate that these women, as a group, were overweight. Although a large percent (63%) were taking calcium supplements, the mean daily intake (diet and supplements) of calcium (1,353 mg) and vitamin D (403 IU) was less than the recommended dietary guidelines for these nutrients in this population. At study entry, 80% of the women were osteopenic (60%) or osteoporotic (20%) and none was receiving treatment/prevention for osteoporosis; only 1 had a previous known osteoporosis diagnosis. This is a special group of women for whom screening and preventive strategies for osteoporosis are imperative.

Original languageEnglish (US)
Pages (from-to)50-56
Number of pages7
JournalCancer Nursing
Volume25
Issue number1
DOIs
StatePublished - Jan 1 2002

Fingerprint

Body Size
Osteoporosis
Survivors
Breast Neoplasms
Hormone Replacement Therapy
Vitamin D
Calcium
Nutrition Policy
Body Mass Index
Diet Records
Weights and Measures
Food
Tamoxifen
Nutritional Status
Forearm
Bone Density
Hip
Spine
Diet
Bone and Bones

Keywords

  • Calcium and vitamin D
  • Nutritional status
  • Osteoporosis risk
  • Survivors of breast cancer

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)

Cite this

Postmenopausal survivors of breast cancer at risk for osteoporosis : Nutritional intake and body size. / Lindsey, Ada M.; Gross, Gloria; Twiss, Janice J; Waltman, Nancy Lauraine; Ott, Carol; Moore, Timothy Eisdell.

In: Cancer Nursing, Vol. 25, No. 1, 01.01.2002, p. 50-56.

Research output: Contribution to journalArticle

@article{9c4a0c8c56aa4ec296beff11cec8472b,
title = "Postmenopausal survivors of breast cancer at risk for osteoporosis: Nutritional intake and body size",
abstract = "Postmenopausal survivors of breast cancer for whom hormone replacement therapy is contraindicated are at risk for development of osteoporosis. The primary purpose of this article is to describe, in a sample of 30 postmenopausal survivors of breast cancer, their calcium and vitamin D intake compared with recommended dietary guidelines for those nutrients for postmenopausal women not taking hormone replacement therapy and the body mass index of these women as nutritional status risk factors for development of osteoporosis. Bone health and presence of osteoporosis were determined by bone mineral density testing of the spine, hip, and forearm. To obtain calcium and vitamin D intake, including supplements, 3-day diet records were completed; height and weight measures were used to calculate body mass index. The sample participants ranged in age from 42 to 65 years; the majority (56{\%}) had been menopausal or off hormone replacement therapy for 5 years or less, and 70{\%} had completed breast cancer treatment for 5 years or less (except tamoxifen). The majority (63{\%}) were of medium body frame size; 30{\%} were of small frame size. The mean body mass index (27.3) and mean weight (160 lbs) indicate that these women, as a group, were overweight. Although a large percent (63{\%}) were taking calcium supplements, the mean daily intake (diet and supplements) of calcium (1,353 mg) and vitamin D (403 IU) was less than the recommended dietary guidelines for these nutrients in this population. At study entry, 80{\%} of the women were osteopenic (60{\%}) or osteoporotic (20{\%}) and none was receiving treatment/prevention for osteoporosis; only 1 had a previous known osteoporosis diagnosis. This is a special group of women for whom screening and preventive strategies for osteoporosis are imperative.",
keywords = "Calcium and vitamin D, Nutritional status, Osteoporosis risk, Survivors of breast cancer",
author = "Lindsey, {Ada M.} and Gloria Gross and Twiss, {Janice J} and Waltman, {Nancy Lauraine} and Carol Ott and Moore, {Timothy Eisdell}",
year = "2002",
month = "1",
day = "1",
doi = "10.1097/00002820-200202000-00010",
language = "English (US)",
volume = "25",
pages = "50--56",
journal = "Cancer Nursing",
issn = "0162-220X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Postmenopausal survivors of breast cancer at risk for osteoporosis

T2 - Nutritional intake and body size

AU - Lindsey, Ada M.

AU - Gross, Gloria

AU - Twiss, Janice J

AU - Waltman, Nancy Lauraine

AU - Ott, Carol

AU - Moore, Timothy Eisdell

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Postmenopausal survivors of breast cancer for whom hormone replacement therapy is contraindicated are at risk for development of osteoporosis. The primary purpose of this article is to describe, in a sample of 30 postmenopausal survivors of breast cancer, their calcium and vitamin D intake compared with recommended dietary guidelines for those nutrients for postmenopausal women not taking hormone replacement therapy and the body mass index of these women as nutritional status risk factors for development of osteoporosis. Bone health and presence of osteoporosis were determined by bone mineral density testing of the spine, hip, and forearm. To obtain calcium and vitamin D intake, including supplements, 3-day diet records were completed; height and weight measures were used to calculate body mass index. The sample participants ranged in age from 42 to 65 years; the majority (56%) had been menopausal or off hormone replacement therapy for 5 years or less, and 70% had completed breast cancer treatment for 5 years or less (except tamoxifen). The majority (63%) were of medium body frame size; 30% were of small frame size. The mean body mass index (27.3) and mean weight (160 lbs) indicate that these women, as a group, were overweight. Although a large percent (63%) were taking calcium supplements, the mean daily intake (diet and supplements) of calcium (1,353 mg) and vitamin D (403 IU) was less than the recommended dietary guidelines for these nutrients in this population. At study entry, 80% of the women were osteopenic (60%) or osteoporotic (20%) and none was receiving treatment/prevention for osteoporosis; only 1 had a previous known osteoporosis diagnosis. This is a special group of women for whom screening and preventive strategies for osteoporosis are imperative.

AB - Postmenopausal survivors of breast cancer for whom hormone replacement therapy is contraindicated are at risk for development of osteoporosis. The primary purpose of this article is to describe, in a sample of 30 postmenopausal survivors of breast cancer, their calcium and vitamin D intake compared with recommended dietary guidelines for those nutrients for postmenopausal women not taking hormone replacement therapy and the body mass index of these women as nutritional status risk factors for development of osteoporosis. Bone health and presence of osteoporosis were determined by bone mineral density testing of the spine, hip, and forearm. To obtain calcium and vitamin D intake, including supplements, 3-day diet records were completed; height and weight measures were used to calculate body mass index. The sample participants ranged in age from 42 to 65 years; the majority (56%) had been menopausal or off hormone replacement therapy for 5 years or less, and 70% had completed breast cancer treatment for 5 years or less (except tamoxifen). The majority (63%) were of medium body frame size; 30% were of small frame size. The mean body mass index (27.3) and mean weight (160 lbs) indicate that these women, as a group, were overweight. Although a large percent (63%) were taking calcium supplements, the mean daily intake (diet and supplements) of calcium (1,353 mg) and vitamin D (403 IU) was less than the recommended dietary guidelines for these nutrients in this population. At study entry, 80% of the women were osteopenic (60%) or osteoporotic (20%) and none was receiving treatment/prevention for osteoporosis; only 1 had a previous known osteoporosis diagnosis. This is a special group of women for whom screening and preventive strategies for osteoporosis are imperative.

KW - Calcium and vitamin D

KW - Nutritional status

KW - Osteoporosis risk

KW - Survivors of breast cancer

UR - http://www.scopus.com/inward/record.url?scp=0036155273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036155273&partnerID=8YFLogxK

U2 - 10.1097/00002820-200202000-00010

DO - 10.1097/00002820-200202000-00010

M3 - Article

C2 - 11838720

AN - SCOPUS:0036155273

VL - 25

SP - 50

EP - 56

JO - Cancer Nursing

JF - Cancer Nursing

SN - 0162-220X

IS - 1

ER -